DOWLING & YAHNKE LLC - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 24 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DOWLING & YAHNKE LLC ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$8,000
+100.0%
22,8700.0%0.00%
Q1 2020$4,000
-20.0%
22,8700.0%0.00%
Q4 2019$5,0000.0%22,8700.0%0.00%
Q3 2019$5,000
-16.7%
22,8700.0%0.00%
Q2 2019$6,000
-45.5%
22,8700.0%0.00%
-100.0%
Q1 2019$11,000
-15.4%
22,8700.0%0.00%0.0%
Q4 2018$13,000
-23.5%
22,8700.0%0.00%0.0%
Q3 2018$17,000
+13.3%
22,8700.0%0.00%0.0%
Q2 2018$15,000
+87.5%
22,8700.0%0.00%0.0%
Q1 2018$8,000
-46.7%
22,8700.0%0.00%0.0%
Q4 2017$15,000
+15.4%
22,8700.0%0.00%0.0%
Q3 2017$13,000
-53.6%
22,8700.0%0.00%
-66.7%
Q2 2017$28,000
-20.0%
22,8700.0%0.00%
-25.0%
Q1 2017$35,000
+75.0%
22,8700.0%0.00%
+100.0%
Q4 2016$20,000
-35.5%
22,8700.0%0.00%
-50.0%
Q3 2016$31,000
-22.5%
22,8700.0%0.00%
-20.0%
Q2 2016$40,000
-13.0%
22,8700.0%0.01%
-16.7%
Q1 2016$46,000
-37.8%
22,8700.0%0.01%
-33.3%
Q4 2015$74,00022,8700.01%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 8,343,716$2,053,0002.58%
Sio Capital Management, LLC 4,935,250$1,214,0000.29%
Endurant Capital Management LP 2,481,355$610,0000.24%
Fosun International Ltd 596,752$147,0000.01%
Malaga Cove Capital, LLC 30,000$7,0000.01%
Summit X, LLC 35,000$8,0000.00%
ARDSLEY ADVISORY PARTNERS LP 75,000$19,0000.00%
Fosun International Ltd 168,851$42,0000.00%
INTRUST BANK NA 40,000$10,0000.00%
Cetera Advisor Networks LLC 142,500$49,0000.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders